Rachel Lenington Athira Pharma, Inc. (ATHA) insider trading activity
Rachel Lenington is COO AND CDO of Athira Pharma, Inc.. Currently has a direct ownership of 13,395 shares of ATHA, which is worth approximately $35,094. The most recent transaction as insider was on Jan 05, 2024, when has been sold 2,412 shares (Common Stock) at a price of $2.91 per share, resulting in proceeds of $7,018. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13.4K
0%
3M change
130.67%
12M change
Total Value Held
$35,094
Rachel Lenington Transaction History
RL
Rachel Lenington
COO AND CDO
Bothell, WA